Australia's most trusted
source of pharma news
Monday, 29 June 2026
Posted 29 June 2026 PM
Over the weekend, Health Minister Mark Butler announced 10 new and expanded PBS listings for July providing “vital financial relief to Australians” battling cancer and chronic conditions.
Among the newcomers to the scheme is AstraZeneca’s pegged blockbuster Tezspire for patients aged 12 years and older whose severe uncontrolled asthma causes a buildup of white blood cells leading to inflammation and tissue damage or causes the immune system to overact to allergens.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.